Targeting cell cycle kinases and kinesins in anticancer drug development
Timothy A. Yap(The University of Texas MD Anderson Cancer Center), Johann S. de Bono(Royal Marsden NHS Foundation Trust), Sarah P. Blagden(Churchill Hospital), L Rhoda Molife(Institute of Cancer Research)
Cited by 15
Related Papers
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
|Journal of Clinical Oncology|2016|1.6k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k